University of Alabama Birmingham
Beyond Chronic Fatigue: Studying The Role Of Neuroinflammation, Glutamate, And Glutamine
Abstract
dc:description.abstractMyalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a complex, multifaceted disease characterized by persistent, severe fatigue lasting six months or longer that is not relieved by rest. An estimated 20 million people worldwide suffer from ME/CFS. ME/CFS has long been suspected to be a post-viral illness, as viral infections can stimulate inflammatory cytokine production. Millions of coronavirus disease 2019 (COVID-19) patients are also predicted to develop persistent symptoms that mimic ME/CFS symptomology after the resolution of the acute infection, referred to as Post-Acute Sequelae of COVID-19 (PASC). Inflammatory mediators produced by sustained microglia activation have been shown to lead to illness response symptoms associated with ME/CFS and PASC. Previous magnetic resonance spectroscopy imaging (MRSI) research has shown that ME/CFS patients exhibit markers of neuroinflammation, such as choline, myoinositol, and lactate. Yet, no studies have examined glutamate (Glu) and glutamine (Gln) in ME/CFS patients using MRSI. Growing evidence suggests that inflammation and alterations in the Glu-Gln cycle are linked. Prior research has also demonstrated that ME/CFS patients exhibit abnormal peripheral Glu and Gln signaling. Also, with ME/CFS involving neuroinflammation indicated by elevated brain temperature and the potential connection between ME/CFS and PASC, few studies have investigated neuroinflammation in PASC patients. This dissertation aims to explore the relationship inflammation has with Glu, Gln, and fatigue in people with ME/CFS, as well as determine if neuroinflammation is present in PASC. Using MRSI, Aim 1 established elevated Gln in the brain of ME/CFS patients compared to healthy controls. Aim 2 measured circulatory inflammation, Glu, and Gln in ME/CFS and healthy controls. We found no differences in Glu, Gln, Interlukin-6, or C-reactive protein, but Tumor Necrosis Factor-alpha was higher in the ME/CFS group. Lastly, Aim 3 demonstrated that there are signs of neuroinflammation present in PASC patients. Together, these studies indicate that dysregulation of the Glu-Gln cycle is only present centrally and that there is emerging evidence of neuroinflammation in PASC patients. These findings provide a foundation for further ME/CFS and PASC research to aid in diagnostic and treatment decisions.
Degree
thesis:*- Name thesis:degree_name
- Doctor of Philosophy (PhD)
- Level thesis:degree_level
- Dissertation
- Discipline thesis:degree_discipline
- Psychology
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Jordan, Indonesia Alohn
- Contributors dc:contributor
-
- <p>Jarred Younger</p>
- <p>David Knight<br>Olivio Clay<br>Robert Sorge<br>Shruti Agnihotri</p>
Subjects
dc:subject × 4Identifiers
dc:identifier.*- Repository record dc:identifier
- https://digitalcommons.library.uab.edu/etd-collection/7607